Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Medullary thyroid cancer accounts for 5-10% of all thyroid cancers. Medullary thyroid cancer is the only thyroid cancer that begins in the C cells. This type of thyroid cancer is easier to control if it is found and treated early, before it spreads to other parts of the body. Learn about our innovative treatments at the Head and Neck Cancer Program.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.